United States · 
What does Galen Partners invest in?
Galen Partners invests most often at Venture and Series C (72% of the rounds on record), in sectors such as Health-tech, E-health and Tech-enabled Health.
Galen Partners highlights
- 01
18 rounds on record
- 02
Mostly Venture and Series C: 72% of its rounds
- 03
Sole investor in 4 rounds, median $11M
- 04
4 exits from the portfolio
What they do
Experienced healthcare investors focused on growth equityFrom their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries BGrowth
- Sectors
- Health-techE-healthTech-enabled Health
- Based in
- Stamford, United States
- Cold pitches
- Not accepted
The record
Every round we can evidence, newest first18 appearances
- 2015
2 rounds
- Sept
- May
- 2013
2 rounds
- Apr
- Feb
- 2012
3 rounds
- Oct
- Mar
- Jan
- 2010
1 round
- Apr
- 2008
2 rounds
- Mar
- Feb
- 2007
3 rounds
- Oct
- Jul
- May
- 2005
1 round
- Sept
- 2004
1 round
- Nov
- 2003
1 round
- Aug
- 2002
1 round
- Sept
- 1999
1 round
- Nov
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration5 named
DWDavid William JahnsManager of the ManageriFiling they signed
LJLouis John WilkersonManaging DirectoriForm ADV
PBPhilip BordenManager of the ManageriFiling they signed
SLStacey Lynn BauerChief Financial OfficeriForm ADV
ZSZubeen ShroffManager of the ManageriFiling they signed
We also hold 23 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$71Mgross assets of its funds, 2 advisers combinedOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- Galen Management, LLC
- SEC number
- CRD 158333
What they claim to have backed
From their own portfolio page (on their website)
0 of 1 we have independently watched raise
Current Investment
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed4 in all
Aperio TechnologiesBought by Leica MicrosystemsUndisclosedAug 2012
ONI Medical Systems, Inc.Bought by GE HealthcareUndisclosedNov 2009
Specialized Health Products InternationalBought by CR Bard (Bard Peripheral Vascular /IMPRA)UndisclosedMar 2008
JDS Pharmaceuticals LLC.Bought by NovenUndisclosedAug 2007
An exit counts when it came after the firm's first round in the company. From historical deal records.